A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

CompletedOBSERVATIONAL

Enrollment

13,264

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

Nintedanib

Nintedanib initiators

DRUG

Pirfenidone

Pirfenidone initiators

OTHER

Untreated Cohort

Untreated

Trial Locations (1)

Plymouth Meeting, Plymouth